Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients

Completed

Conditions studied: Anal Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Lung Cancer

In brief

Primary Objectives: * To determine the feasibility of a study that would describe changes of certain circulating inflammatory cytokines (interleukin-1, 6, 8, 10, 12, and tumor necrosis factor-alpha \[TNF\] and symptoms related to chemoradiation therapy (pre-therapy, during therapy and up to 3 months post-therapy) among patients with lung, esophageal, gastric, colorectal and anal cancer. * To determine the feasibility of studying neurocognitive function in patients with non-small cell lung cancer (NSCLC) at presentation and during chemoradiation therapy to determine the prevalence, severity, and pattern of cognitive symptoms.

Key facts

Study ID

NCT00502502

Run by

M.D. Anderson Cancer Center

People needed

205

Starts

2002-11-01

Expected to finish

2010-07-01

Last updated by the study team

2012-07-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled for chemoradiation therapy at MDACC.
• Adults > 18 years of age.
• Diagnosis of lung, esophageal, gastric, colorectal, or anal cancer.
• English-speaking.
• Lives in the United States.
• Adequate vision and hearing to use the IVR system.
• Provides written informed consent.

You may not qualify if…

• Patients with a current diagnosis of psychosis or dementia.
• Patients who are unable to complete the assessment measures or refuse to participate.

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.